http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070055486-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c4986e3f6d0c211b4f816b28ff22b0e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate | 2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6a2133b191176160a44eab3f39e486a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19745cd469a624f2ace13852889126b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a66655be266675b9232a090f05d2cf3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6a226c7df3f4fc681d0a1caedefaeb9 |
| publicationDate | 2007-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20070055486-A |
| titleOfInvention | Puranopyrimidine Compounds Effective as Potassium Channel Inhibitors |
| abstract | A compound of Formula 1 or a pharmaceutically acceptable salt thereof:n n n n Formula 1n n n n n n n n n In the above formula, R 1 is aryl, heteroaryl, cycloalkyl or alkyl; R2 is H, alkyl, nitro, -C0 2 R7, CONR4R5 or halo; R 3 is H, NR 4 R 5, NC (O) R 8, halo, trifluoromethyl, alkyl, nitrile or alkoxy; R 4 and R 5 may be the same or different and may be H, alkyl, aryl, heteroaryl or cycloalkyl; Or R 4 and R 5 may together form a saturated, unsaturated or partially saturated 4 to 7 membered ring, which ring may optionally comprise one or more heteroatoms selected from N, 0 or S and ; X is 0, S or NR 6; R 6 is H or alkyl; R 7 is hydrogen, methyl or ethyl; R8 is methyl or ethyl; L is (CH 2 ) n , where n is 1, 2 or 3; And Y is aryl, heterocycle group, alkyl, alkenyl or cycloalkyl. Also described is the use of such compounds as potassium channel inhibitors.n n n Furanopyrimidine, compound, potassium channel, inhibitor, arrhythmia |
| priorityDate | 2004-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 177.